Physician profile
Ginger Dean
NPI 1659830057
$1,048.79
in general payments reported to CMS, 2019-2025
8 companies · $417 in 2025
The $417 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $301 · 2024: $330 · 2025: $417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,049.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,048.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $346.53 | 2024-2025 | Evenity |
| Reprise Biomedical, INC. | $148.40 | 2024 | Miro3d |
| Lilly USA, LLC | $116.73 | 2023 | Mounjaro |
| Gilead Sciences, INC. | $110.93 | 2025 | Epclusa |
| Abbvie INC. | $97.14 | 2023 | |
| Kyowa Kirin, INC. | $91.04 | 2024 | |
| Kci USA, INC. | $87.60 | 2023 | Activ.A.C., Promogran Prisma, Snap |
| Boston Scientific Corporation | $50.42 | 2025 | Apollo Esg System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ginger Dean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.